Biomaterial Wound Dressing Market Share, Size, Trends, Industry Analysis Report, By Product (Natural and Synthetic); By Application; By End Use; By Region; Segment Forecast, 2024 - 2032

Biomaterial Wound Dressing Market Share, Size, Trends, Industry Analysis Report, By Product (Natural and Synthetic); By Application; By End Use; By Region; Segment Forecast, 2024 - 2032

The global biomaterial wound dressing market size is expected to reach USD 11.93 billion by 2032, according to a new study by Polaris Market Research. The report “Biomaterial Wound Dressing Market Share, Size, Trends, Industry Analysis Report, By Product (Natural and Synthetic); By Application; By End Use; By Region; Segment Forecast, 2024 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The increasing burden of chronic wounds and associated problems and the rising prevalence of several lifestyle disorders like diabetes and heart disease that result in pressure ulcers, venous ulcers, and diabetic foot ulcers are prominent factors fostering global market growth. Additionally, the widespread use of biomaterials like alginate and chitosan in wound care due to their hydrophilic nature and ability to adapt different forms, including blends, dressings, beads, hydrogels, and electrospun scaffolds, is further anticipated to contribute to the market’s growth.

Among patients with diabetes, the risk of developing a foot ulcer is nearly 25% during their lifetime, and 15% of which progress to amputation. In addition, around 3.5 to 69 percent of patients are affected by pressure injuries in hospitals every year, which might result in wound-related mortality and infections. Pressure injuries in the United States cost around USD 9.1 to 100.6 billion each year. Besides this, burn is also a major injury associated with USD 1.5 billion in medical costs and USD 5 billion in lost workdays.

Studies have shown that innovative biomaterials offer promise for regeneration and support the overall skin matrices to facilitate tissue growth. For instance, UC Davis said that they have developed the LXW7 molecule, which interacts with the endothelial cells, helping with attachment, migration, & survival. When added to the scaffolds, they offer a gripping site for endothelial cells and enable efficient interaction between the cells & the supportive structure.

Moreover, government authorities worldwide are providing grants and implementing several favorable initiatives that encourage companies to develop new and more efficient wound care products, which positively impacts the market’s growth. For instance, in October 2023, Gel4Med announced that the US Food and Drug Administration has granted 510(k) clearance to its biosynthetic matrix products, which are designed to transform wound management.

Biomaterial Wound Dressing Market Report Highlights

The natural segment captured the largest share, which is attributed to the growing adoption of wound dressings with natural ingredients due to their properties

Chronic wounds segment accounted for a notable share, owing to the increasing prevalence of chronic wounds and the introduction of advanced chronic wound care products

The home healthcare segment will grow at the highest pace due to the rising elderly population who require home-based healthcare settings, including wound care

North America dominated the global market on account of the robust presence of well-established healthcare infrastructure and technological advancements in wound care

The key market players include Advanced Medical Solutions Group, ConvaTec Group, Hollister Incorporated, Integra LifeSciences Holdings, and BSN Medical

Polaris Market Research has segmented the biomaterial wound dressing market report based on product, application, end-use, and region:

Biomaterial Wound Dressing, Product Outlook (Revenue - USD Billion, 2019 - 2032)

Natural

Alginate

Honey

Collagen

Chitosan

Carboxymethyl Cellulose

Others

Synthetic

Polyurethane

Silicone

Others

Biomaterial Wound Dressing, Application Outlook (Revenue - USD Billion, 2019 - 2032)

Chronic Wounds

Diabetic Foot Ulcers

Pressure Ulcers

Venous Leg Ulcers

Other Chronic Wounds

Acute Wounds

Surgical & Traumatic Wounds

Burns

Biomaterial Wound Dressing, End-Use Outlook (Revenue - USD Billion, 2019 - 2032)

Hospitals

Outpatient Facilities

Home Healthcare

Research & Manufacturing

Biomaterial Wound Dressing, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa